These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 845790)

  • 1. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.
    Boxenbaum HG; Geitner KA; Jack ML; Dixon WR; Spiegel HE; Symington J; Christian R; Moore JD; Weissman L; Kaplan SA
    J Pharmacokinet Biopharm; 1977 Feb; 5(1):3-23. PubMed ID: 845790
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.
    Boxenbaum HG; Geitner KA; Jack ML; Dixon WR; Kaplan SA
    J Pharmacokinet Biopharm; 1977 Feb; 5(1):25-39. PubMed ID: 845789
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption of oral and intramuscular chlordiazepoxide.
    Greenblatt DJ; Shader RI; MacLeod SM; Sellers EM; Franke K; Giles HG
    Eur J Clin Pharmacol; 1978 Jun; 13(4):267-74. PubMed ID: 668784
    [No Abstract]   [Full Text] [Related]  

  • 4. Slow absorption of intramuscular chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J
    N Engl J Med; 1974 Nov; 291(21):1116-8. PubMed ID: 4416981
    [No Abstract]   [Full Text] [Related]  

  • 5. Absorption of oral intramuscular chlordiazepoxide by alcoholics.
    Perry PJ; Wilding DC; Fowler RC; Hepler CD; Caputo JF
    Clin Pharmacol Ther; 1978 May; 23(5):535-41. PubMed ID: 639427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of chlordiazepoxide.
    Greenblatt DJ; Shader RI; MacLeod SM; Sellers EM
    Clin Pharmacokinet; 1978; 3(5):381-94. PubMed ID: 359214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular injections and bioavailability.
    Tuttle CB
    Am J Hosp Pharm; 1977 Sep; 34(9):965-8. PubMed ID: 333911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of drugs administered intramuscularly.
    Thomas J
    Aust Fam Physician; 1977 Aug; 6(8):925-34. PubMed ID: 921622
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological half-life of chlordiazepoxide and its metabolite, demoxepam, in man.
    Schwartz MA; Postma E; Gaut Z
    J Pharm Sci; 1971 Oct; 60(10):1500-3. PubMed ID: 5129365
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of oral and intramuscular routes of administration on serum chlordiazepoxide levels and the prediction of these levels from predrug fasting serum glucose concentrations.
    Gottschalk LA; Biener R; Dinovo EC
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):697-702. PubMed ID: 4607746
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic determinants of the response to single doses of chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J
    Am J Psychiatry; 1974 Dec; 131(12):1395-7. PubMed ID: 4432941
    [No Abstract]   [Full Text] [Related]  

  • 12. Alcohol and the benzodiazepines. The interaction between intravenous ethanol and chlordiazepoxide and diazepam.
    Dundee JW; Howard AJ; Isaac M
    Q J Stud Alcohol; 1971 Dec; 32(4):960-8. PubMed ID: 5137095
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).
    Roberts RK; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1978 Sep; 75(3):479-85. PubMed ID: 680505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absorption of intramuscular chlordiazepoxide (Librium) in patients with severe alcoholic liver disease.
    Robinson JD; Whitney HA; Guisti DL; Morgan DD; Mendenhall CL
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):433-8. PubMed ID: 6629548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of benzodiazepine pharmacokinetics.
    Shader RI; Greenblatt DJ
    Am J Psychiatry; 1977 Jun; 134(6):652-6. PubMed ID: 17302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic model for chlordiazepoxide--HCl in the dog.
    Kaplan SA; Lewis M; Schwartz MA; Postma E; Cotler S; Abruzzo CW; Lee TL; Weinfeld RE
    J Pharm Sci; 1970 Nov; 59(11):1569-74. PubMed ID: 5495479
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic procedures in cases of severe delirium tremens].
    Góraj A
    Psychiatr Pol; 1975; 9(1):71-6. PubMed ID: 1090965
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption rate, blood concentrations, and early response to oral chlordiazepoxide.
    Greenblatt DJ; Shader RI; Harmatz JS; Franke K; Koch-Weser J
    Am J Psychiatry; 1977 May; 134(5):559-62. PubMed ID: 848586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
    Wilkinson GR
    Acta Psychiatr Scand Suppl; 1978; (274):56-74. PubMed ID: 32740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.